$AGN Recent News In focus: Challenging the all
Post# of 94145
Posted On: 04/25/2014 11:45:39 AM
$AGN Recent News
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off-the-radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan soars on Valeant bid; Netflix jumps on results 3:12 p.m. April 22, 2014 - Saumya Vaishampayan
Investors anticipate higher Allergan bids amid Valeant's hostile takeover 12:27 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan surges 15% on Valeant offer 9:32 a.m. April 22, 2014 - Sue Chang
Bear call on GE, wads of drug(maker) cash, Netflix price hike 9:26 a.m. April 22, 2014 - blogs.marketwatch.com
Stock futures edge higher; Allergan jumps on deal news 8:59 a.m. April 22, 2014 - Sara Sjolin
Valeant, Ackman propose Allergan deal 8:13 a.m. April 22, 2014 - David Benoit
Allergan, Valeant shares rally on buyout offer 8:02 a.m. April 22, 2014 - Ben Eisen
Valeant: 0.83 share plus $48.30 per Allergan share 7:48 a.m. April 22, 2014 - Ben Eisen
McDonald’s, Gilead, Yum, AT&T are stocks to watch 5:56 a.m. April 22, 2014 - Sue Chang
Valeant's ravenous buyout appetite reappears with Allergan proposal 6:38 p.m. April 21, 2014 - blogs.marketwatch.com
Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal 49 min ago - GuruFocus.com
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. Today - Zacks.com
Allergan Leads 30 Best Value Bond Trades With Maturities Of 1 Year Or More, April 24 9:10 p.m. April 24, 2014 - Seeking Alpha
Update on Glaxo/Theravance's COPD Drugs - Analyst Blog 6:33 p.m. April 24, 2014 - Zacks.com
Valeant Eyes Allergan - Analyst Blog 5:40 p.m. April 24, 2014 - Zacks.com
Allergan Investor Doesn't Favor Offer 5:25 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:16 p.m. April 24, 2014 - CNW Group
Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog 1:50 p.m. April 24, 2014 - Zacks.com
Zimmer Bolts on Biomet for $13.4B 11:47 a.m. April 24, 2014 - TheStreet.com
Botox at the Center of Recent Healthcare M&A Flurry 11:07 a.m. April 24, 2014 - TheStreet.com
Cramer's Mad Money - Why Isn't The Selling More Pronounced (4/23/14) 5:57 a.m. April 24, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's New Reality 8:20 p.m. April 23, 2014 - TheStreet.com
Encouraging Results from Pfizer's Xeljanz - Analyst Blog 6:20 p.m. April 23, 2014 - Zacks.com
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen 6:03 p.m. April 23, 2014 - GuruFocus.com
Three Valeant Directors Won't Be Nominated for Re-Election 5:21 p.m. April 23, 2014 - The Wall Street Journal Interactive Edition
Allergan Inc (AGN): Today's Featured Drugs Winner 5:00 p.m. April 23, 2014 - TheStreet.com
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium 3:46 p.m. April 23, 2014 - GuruFocus.com
Biggest Movers in Healthcare Stocks Now – QCOR AGN IDXX WCG 1:45 p.m. April 23, 2014 - InvestorPlace.com
Follow the Leaders Today 1:00 p.m. April 23, 2014 - RealMoney.com
Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan 10:25 a.m. April 23, 2014 - Wall St. Cheat Sheet
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. Today - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
Allergan Announces Quarterly Conference Call 5:30 p.m. April 4, 2014 - BusinessWire - BZX
In focus: Challenging the all-time highs 9:45 p.m. April 23, 2014 - Lawrence G. McMillan
How to find off-the-radar stocks 12:07 p.m. April 23, 2014 - blogs.marketwatch.com
Ackman says he's in it for long haul on proposed Valeant-Allergan deal 11:59 a.m. April 23, 2014 - blogs.marketwatch.com
Ackman: Didn't violate insider-trading rules over Allergan 7:58 a.m. April 23, 2014 - Silvia Ascarelli
Ackman: Allergan poison pill lets board explore options 7:42 a.m. April 23, 2014 - Silvia Ascarelli
Game day for Facebook and Apple, volume 'signalling the nasty' 6:50 a.m. April 23, 2014 - blogs.marketwatch.com
Allergan adopts poison pill in face of Valeant bid 3:48 a.m. April 23, 2014 - Liz Hoffman
U.S. stocks gain; S&P 500 extends streak to six 5:14 p.m. April 22, 2014 - Anora Mahmudova
Newscast: Stocks notch another win 4:32 p.m. April 22, 2014 - MarketWatch
S&P 500, Nasdaq extend win streak to 6 sessions: Stock market live blog recap 3:56 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan soars on Valeant bid; Netflix jumps on results 3:12 p.m. April 22, 2014 - Saumya Vaishampayan
Investors anticipate higher Allergan bids amid Valeant's hostile takeover 12:27 p.m. April 22, 2014 - blogs.marketwatch.com
Allergan surges 15% on Valeant offer 9:32 a.m. April 22, 2014 - Sue Chang
Bear call on GE, wads of drug(maker) cash, Netflix price hike 9:26 a.m. April 22, 2014 - blogs.marketwatch.com
Stock futures edge higher; Allergan jumps on deal news 8:59 a.m. April 22, 2014 - Sara Sjolin
Valeant, Ackman propose Allergan deal 8:13 a.m. April 22, 2014 - David Benoit
Allergan, Valeant shares rally on buyout offer 8:02 a.m. April 22, 2014 - Ben Eisen
Valeant: 0.83 share plus $48.30 per Allergan share 7:48 a.m. April 22, 2014 - Ben Eisen
McDonald’s, Gilead, Yum, AT&T are stocks to watch 5:56 a.m. April 22, 2014 - Sue Chang
Valeant's ravenous buyout appetite reappears with Allergan proposal 6:38 p.m. April 21, 2014 - blogs.marketwatch.com
Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal 49 min ago - GuruFocus.com
AstraZeneca Misses Earnings But Up on Takeover Rumors - Analyst Blog 10:30 a.m. Today - Zacks.com
Allergan Leads 30 Best Value Bond Trades With Maturities Of 1 Year Or More, April 24 9:10 p.m. April 24, 2014 - Seeking Alpha
Update on Glaxo/Theravance's COPD Drugs - Analyst Blog 6:33 p.m. April 24, 2014 - Zacks.com
Valeant Eyes Allergan - Analyst Blog 5:40 p.m. April 24, 2014 - Zacks.com
Allergan Investor Doesn't Favor Offer 5:25 p.m. April 24, 2014 - The Wall Street Journal Interactive Edition
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:16 p.m. April 24, 2014 - CNW Group
Eli Lilly Q1 Earnings In-Line, Revenues Miss - Analyst Blog 1:50 p.m. April 24, 2014 - Zacks.com
Zimmer Bolts on Biomet for $13.4B 11:47 a.m. April 24, 2014 - TheStreet.com
Botox at the Center of Recent Healthcare M&A Flurry 11:07 a.m. April 24, 2014 - TheStreet.com
Cramer's Mad Money - Why Isn't The Selling More Pronounced (4/23/14) 5:57 a.m. April 24, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's New Reality 8:20 p.m. April 23, 2014 - TheStreet.com
Encouraging Results from Pfizer's Xeljanz - Analyst Blog 6:20 p.m. April 23, 2014 - Zacks.com
Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen 6:03 p.m. April 23, 2014 - GuruFocus.com
Three Valeant Directors Won't Be Nominated for Re-Election 5:21 p.m. April 23, 2014 - The Wall Street Journal Interactive Edition
Allergan Inc (AGN): Today's Featured Drugs Winner 5:00 p.m. April 23, 2014 - TheStreet.com
Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium 3:46 p.m. April 23, 2014 - GuruFocus.com
Biggest Movers in Healthcare Stocks Now – QCOR AGN IDXX WCG 1:45 p.m. April 23, 2014 - InvestorPlace.com
Follow the Leaders Today 1:00 p.m. April 23, 2014 - RealMoney.com
Pharma Drama: Pfizer Fails to Woo AstraZeneca; Valeant Pursues Allergan 10:25 a.m. April 23, 2014 - Wall St. Cheat Sheet
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. Today - PR Newswire - PRF
Valeant And Pershing Square Investor Meeting Webcast Replay And Presentations Now Available 3:15 p.m. April 24, 2014 - PR Newswire - PRF
Stock Price Updates, Acquisition Proposals, Upcoming Events, Senior Level Appointments, and Pending Acquisition - Analyst Notes on AstraZeneca, Valeant, WellPoint, Illumina and Forest 8:00 a.m. April 24, 2014 - PR Newswire - PRF
Fitch Places Allergan's Ratings on Negative Watch 3:32 p.m. April 23, 2014 - BusinessWire - BZX
PharmaPoint: Migraine - US Drug Forecast and Market Analysis to 2023 12:30 p.m. April 23, 2014 - PR Newswire - PRF
Critical Alerts For Allergan, SunEdison, Valeant Pharmaceuticals, Shire PLC, and Paychex Released By InvestorsObserver 9:31 a.m. April 23, 2014 - PR Newswire - PRF
Allergan Adopts One-Year Stockholder Rights Plan 8:25 p.m. April 22, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT:Brower Piven Announces the Investigation of Allergan Inc. over the Proposed Takeover of the Company 11:17 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Confirms Receipt of Unsolicited Proposal from Valeant 11:00 a.m. April 22, 2014 - BusinessWire - BZX
ALLERGAN, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal 10:12 a.m. April 22, 2014 - BusinessWire - BZX
Allergan Notes Public Filings by Valeant and Pershing Square 10:45 p.m. April 21, 2014 - BusinessWire - BZX
Dr. Rian A. Maercks Announces Appointment to Elite ASCENT National Advisory Panel in Plastic Surgery, Comprised of Top 25 Leaders in Innovative Plastic Surgery in the U.S. 8:45 a.m. April 17, 2014 - PR Newswire - PRF
TauTona Group Sells Aline HA(R) to Allergan 8:30 a.m. April 17, 2014 - Marketwire
Global Laparoscopic Devices Industry 4:19 p.m. April 16, 2014 - PR Newswire - PRF
Top-of-Mind Companies in Facial Injectable and Laser/Energy Device Markets Are Similar in Europe and Asia 10:00 a.m. April 15, 2014 - PR Newswire - PRF
Active Equities under the Scanner -- Research on Allergan, Visa, Starbucks, and Home Depot 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Sientra Appoints Charlie Huiner as Chief Strategy and Corporate Development Officer 2:00 p.m. April 8, 2014 - BusinessWire - BZX
Diabetic Macular Edema Global Clinical Trials Review, H2, 2013 10:32 a.m. April 8, 2014 - PR Newswire - PRF
Allergan Announces Quarterly Conference Call 5:30 p.m. April 4, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼